Allison Van Lint

Allison started life as an immunologist with post-doctoral studies at the Harvard Medical School. She spent time in the world of public health research, in the areas of intensive care medicine and pediatric clinical trials, before joining the internal global equities team at Cbus in 2017. Allison recently made the move to responsible investments at Cbus where she leads the research team with a focus on climate change and emerging issues within the RI space.